These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intravenous administration of prostaglandin PGE2 - emergency therapy of critical hypoxia in cyanotic heart defects in the neonatal period]. Nekvasil R; Stejskal J; Procházka J; Muchová M; Dolezel Z Cesk Pediatr; 1982 Aug; 37(8):439-45. PubMed ID: 6957272 [No Abstract] [Full Text] [Related]
3. Acidemia of cardiogenic origin in young infants with cyanotic congenital heart abnormalities. Pathogenesis, diagnosis and treatment, with particular emphasis on neonatal acid-base disturbance. Folger GM Clin Pediatr (Phila); 1972 Oct; 11(10):573-9. PubMed ID: 5078532 [No Abstract] [Full Text] [Related]
4. Reversal of curarization with atropine-neostigmine mixture in patients with congenital cardiac disease. Salem MR; Ylagan LB; Angel JJ; Vedam VS; Collins VJ Br J Anaesth; 1970 Nov; 42(11):991-8. PubMed ID: 5488363 [No Abstract] [Full Text] [Related]
5. [Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants]. Dymnicka S; Bielińska B; Ereciński J; Machnowski W Pediatr Pol; 1981 Oct; 56(10):1243-8. PubMed ID: 7199703 [No Abstract] [Full Text] [Related]
6. [The effect of atropine on the heart rate of the fetus and the newborn infant]. Junge HD; Loch W Z Geburtshilfe Gynakol; 1971; 174(1):22-35. PubMed ID: 5554804 [No Abstract] [Full Text] [Related]
7. The cyanotic newborn: approach to diagnosis and treatment. Rashkind WJ Cardiovasc Clin; 1972; 4(3):275-80. PubMed ID: 4130207 [No Abstract] [Full Text] [Related]
8. [Prostaglandin E1 therapy in infants with cyanotic congenital heart malformations: hemodynamic and angiographic findings (author's transl)]. Schumacher G; Mocellin R; Schöber JG; Kellner M; Bühlmeyer K Klin Padiatr; 1978 Sep; 190(5):465-73. PubMed ID: 568198 [TBL] [Abstract][Full Text] [Related]
9. Chronic hypoxemia in children with cyanotic heart disease. O'Brien P; Smith PA Crit Care Nurs Clin North Am; 1994 Mar; 6(1):215-26. PubMed ID: 8192880 [TBL] [Abstract][Full Text] [Related]
11. NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients. Piccoli M; Conforti E; Varrica A; Ghiroldi A; Cirillo F; Resmini G; Pluchinotta F; Tettamanti G; Giamberti A; Frigiola A; Anastasia L Int J Cardiol; 2017 Mar; 230():6-13. PubMed ID: 28038803 [TBL] [Abstract][Full Text] [Related]
12. Nasotracheal intubation in the neonate: physiologic responses and effects of atropine and pancuronium. Kelly MA; Finer NN J Pediatr; 1984 Aug; 105(2):303-9. PubMed ID: 6747766 [TBL] [Abstract][Full Text] [Related]
13. Retinopathy of prematurity in infants with cyanotic congenital heart disease. Johns KJ; Johns JA; Feman SS; Dodd DA Am J Dis Child; 1991 Feb; 145(2):200-3. PubMed ID: 1994687 [TBL] [Abstract][Full Text] [Related]
14. Myocardial infarction in a neonate with cyanotic congenital heart disease. de Moor MM; Vosloo SM; Human DG Pediatr Cardiol; 1986; 6(4):219-21. PubMed ID: 3703695 [No Abstract] [Full Text] [Related]
15. The Wolff-Parkinson-White syndrome and general anaesthesia. Hannington-Kiff JG Br J Anaesth; 1968 Oct; 40(10):791-5. PubMed ID: 5698536 [No Abstract] [Full Text] [Related]